{"id":"W2560819401","doi":"10.1182/blood.v104.11.866.866","title":"A Multicentre, Double-Blind, Randomized, Phase 2 Trial Comparing Pegfilgrastim with Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Filgrastim; Pegfilgrastim; Medicine; Cytarabine; Chemotherapy; Febrile neutropenia; Neutropenia; Idarubicin; Induction chemotherapy; Internal medicine; Granulocyte colony-stimulating factor; Surgery; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002496903,0.0003703291,0.001067195,0.0001949999,0.0002242157,0.00008772399,0.0001640549,0.0001174698,0.0001675758],"category_scores_gemma":[0.00004424212,0.0002794723,0.0003028387,0.0003643392,0.00009871077,0.0001660799,0.00002473573,0.0002574956,0.0000681032],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001057987,"about_ca_system_score_gemma":0.000430175,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003630153,"about_ca_topic_score_gemma":0.0003151097,"domain_scores_codex":[0.9980677,0.00003901255,0.0004649539,0.0005726513,0.0003435717,0.0005120919],"domain_scores_gemma":[0.9985767,0.0001028395,0.0001558147,0.0004576164,0.0002058746,0.0005011336],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.986225,0.003796245,0.0001378103,0.0000384044,0.001280175,0.00005767389,0.000589027,0.000261339,0.00620772,0.0003015919,0.000194445,0.0009105714],"study_design_scores_gemma":[0.9398224,0.00580015,0.0000363612,0.0001423438,0.003115643,0.0002356429,0.0001038884,0.00008355056,0.04881723,0.00008929132,0.001417512,0.0003359283],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9802486,0.00006926139,0.008728706,0.000861393,0.0003571192,0.008104275,0.00002710463,0.0001818591,0.001421731],"genre_scores_gemma":[0.9881155,0.00004389339,0.007029911,0.001042892,0.001073544,0.001981005,0.0001613162,0.00009058534,0.000461278],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04640254,"threshold_uncertainty_score":0.9999657,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03301226243484864,"score_gpt":0.3518987898533572,"score_spread":0.3188865274185085,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}